source
- Marrow Therapeutics raises $173 million to develop infusion therapy for sickle cell diseaseMarrow Therapeutics was announced on Tuesday by biotech entrepreneur Romesh Subramanian. The new company aims to create an infusion therapy for sickle cell disease that matches the efficacy of gene…
- Flagship invests £100 million to launch AI-native biotech platform hub in the United KingdomFlagship announced it will allocate £100 million to establish a new biotech creation outpost in the United Kingdom. The outpost will focus on building AI-native platform companies that aim to addr…